Latest

Scientists funded by the National Institutes of Health have discovered why GLP-1 based weight loss medications often reach a plateau over time. The research reveals that semaglutide, the active ingredient in Ozempic and Wegovy, triggers varying responses in the brain cells responsible for controlling appetite. The findings offer insight into

A significant international study involving extensive research may challenge decades of standard practice in treating heart attacks. The findings suggest that beta blockers, a class of drugs routinely administered to millions of patients following uncomplicated heart attacks, offer no discernible benefit for individuals whose heart function remains normal post-event. Furthermore,